Found 237 matching trials
SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients PHASE2 Open label multicentric randomized phase II trial, using high throughput ge...
Show More Location
Centre Hospitalier Henri Duffau
Learn More & Join Trial
Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC PHASE1 The combination of chemotherapy with PD-1 immune checkpoint blockade agents...
Show More Status
Active Not Recruiting
Location
Institut Jules Bordet
Learn More & Join Trial
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer PHASE1 This clinical trial will be conducted as a single-center, open-label, Phase...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy PHASE2 Underlying disease mechanisms are fundamental for correct treatment selecti...
Show More Location
Department of Radiology, IRCCS Ospedale San Raffaele
Learn More & Join Trial
Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab PHASE4 Lung cancer presents a significant treatment challenge, particularly in the...
Show More Location
Amsterdam UMC, location VU Medical center
Learn More & Join Trial
Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC PHASE2 This is a Phase II, open label, randomized study of durvalumab in combinati...
Show More Location
Huntsman Cancer Institute at University of Utah
Learn More & Join Trial
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer PHASE1 This is a randomized, open, comparative, multi-centre study which will recr...
Show More Location
Institut Ste Catherine
Learn More & Join Trial
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC PHASE1 This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Show More Location
Research Facility
Learn More & Join Trial
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach PHASE2 Combined-modality treatment of localized muscle invasive bladder cancer inc...
Show More Location
Instituto Catalán de Oncología Badalona
Learn More & Join Trial
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer PHASE2 This study aims to assess the efficacy of durvalumab in combination with ra...
Show More Location
Centre Oscar Lambret, CLCC UNICANCER
Learn More & Join Trial